No Widgets found in the Sidebar

Denosumab

Denosumab is a fully human monoclonal antibody for the treatment of osteoporosis, treatment induced bone loss, bone metastases, rheumatoid arthritis, multiple myeloma and giant cell tumor of bone. Denosumab is…

Read More

Denosumab

Denosumab is a RANK ligand (RANKL) inhibitor indicated for:  Treatment of postmenopausal women with osteoporosis at high risk for fracture Mechanism of action: Denosumab binds to RANKL, a transmembrane or…

Read More